Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maksim Mamonkin

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Blood|June 1, 2023
Splendid isolationDimitrios Laurin Wagner, Maksim Mamonkin
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2019
Analysis of CAR-Mediated Tonic SignalingHugo Calderon, Maksim Mamonkin, Sonia Guedan
European Journal of Immunology|December 17, 2013
Transcription factor ELF4 promotes development and function of memory CD8(+) T cells in Listeria monocytogenes infectionMaksim Mamonkin, Monica Puppi, H Daniel Lacorazza
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 24, 2020
CRISPR-Edited Immune Effectors: The End of the BeginningFeiyan Mo, Helen E Heslop, Maksim Mamonkin
Frontiers in Oncology|March 21, 2019
Chimeric Antigen Receptors for T-Cell MalignanciesLauren D Scherer, Malcolm K Brenner, Maksim Mamonkin
Cancer Journal (Sudbury, Mass.)|May 29, 2019
Adoptive Cell Therapy for Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic LeukemiaPremal D Lulla, Maksim Mamonkin, Malcolm K Brenner
Trends in Immunology|February 4, 2021
Taking T-Cell Oncotherapy Off-the-ShelfFeiyan Mo, Maksim Mamonkin, Malcolm K Brenner, et al.
Nature Immunology|May 5, 2009
Transcription factor ELF4 controls the proliferation and homing of CD8+ T cells via the Krüppel-like factors KLF4 and KLF2Takeshi Yamada, Chun Shik Park, Maksim Mamonkin, et al.
Blood|June 10, 2015
A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignanciesMaksim Mamonkin, Rayne H Rouce, Haruko Tashiro, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Engineering CAR-Vδ2 T cells to boost persistence and anti-tumor functionLeonard Leong, Mansi Narula, Johannes Englisch, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Blood|June 1, 2023
Splendid isolationDimitrios Laurin Wagner, Maksim Mamonkin
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2019
Analysis of CAR-Mediated Tonic SignalingHugo Calderon, Maksim Mamonkin, Sonia Guedan
European Journal of Immunology|December 17, 2013
Transcription factor ELF4 promotes development and function of memory CD8(+) T cells in Listeria monocytogenes infectionMaksim Mamonkin, Monica Puppi, H Daniel Lacorazza
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 24, 2020
CRISPR-Edited Immune Effectors: The End of the BeginningFeiyan Mo, Helen E Heslop, Maksim Mamonkin
Frontiers in Oncology|March 21, 2019
Chimeric Antigen Receptors for T-Cell MalignanciesLauren D Scherer, Malcolm K Brenner, Maksim Mamonkin
Cancer Journal (Sudbury, Mass.)|May 29, 2019
Adoptive Cell Therapy for Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic LeukemiaPremal D Lulla, Maksim Mamonkin, Malcolm K Brenner
Trends in Immunology|February 4, 2021
Taking T-Cell Oncotherapy Off-the-ShelfFeiyan Mo, Maksim Mamonkin, Malcolm K Brenner, et al.
Nature Immunology|May 5, 2009
Transcription factor ELF4 controls the proliferation and homing of CD8+ T cells via the Krüppel-like factors KLF4 and KLF2Takeshi Yamada, Chun Shik Park, Maksim Mamonkin, et al.
Blood|June 10, 2015
A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignanciesMaksim Mamonkin, Rayne H Rouce, Haruko Tashiro, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Engineering CAR-Vδ2 T cells to boost persistence and anti-tumor functionLeonard Leong, Mansi Narula, Johannes Englisch, et al.
Pageof 6